Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kavita Kalidas"'
Autor:
David Kudrow, Rima Dafer, David W. Dodick, Amaal Starling, Jessica Ailani, Carrie Dougherty, Kavita Kalidas, Feng Zhang, Rohini Jeswani, Nishil Patel, Ani C. Khodavirdi
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:418-428
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::923ab4dd510a76fafcb70da0fdc19622
https://doi.org/10.1111/head.14485
https://doi.org/10.1111/head.14485
Autor:
James M. Martinez, Nada Hindiyeh, Sandra Garces, Greg Anglin, William Kielbasa, Kavita Kalidas, Brian A. Moser, Eric M. Pearlman, Michael E Hodsdon
Publikováno v:
Cephalalgia
Background This analysis characterizes the immunogenicity profile of galcanezumab, a humanized monoclonal antibody that selectively binds calcitonin gene-related peptide and inhibits its activity, in phase 3 migraine trials. Methods Immunogenicity da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23514b639128bff65a85e658c7542279
https://doi.org/10.1177/0333102420920642
https://doi.org/10.1177/0333102420920642
Publikováno v:
Cephalalgia
Background Sustained pain freedom is an important attribute of acute migraine therapies for patients and physicians. Here we report efficacy of the centrally penetrant, highly selective, 5-HT1F agonist lasmiditan on sustained pain freedom and other o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3841f9559cd6a8d56183722d1ec3bd
https://doi.org/10.1177/0333102419859313
https://doi.org/10.1177/0333102419859313
Autor:
Réza Behrouz, Kavita Kalidas
Publikováno v:
Expert Review of Neurotherapeutics. 8:1731-1741
The association of genetic factors and cerebral infarction (CI) has long been established. A positive family history alone is a recognized risk factor for CI and vascular events in general. However, there are certain inherited conditions that further
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56049ae51912e7220a2d411e0720684f
https://doi.org/10.1586/14737175.8.11.1731
https://doi.org/10.1586/14737175.8.11.1731
Autor:
Lara Katzin, Ali Bozorg, Melissa Giarratano, Selim R. Benbadis, Amanda Smith, Derrick Robertson, Juan Sanchez-Ramos, Kavita Kalidas, Tuan Vu, Theresa A. Zesiewicz
Publikováno v:
Expert review of neurotherapeutics. 14(12)
Constituents of the Cannabis plant, cannabinoids, may be of therapeutic value in neurologic diseases. The most abundant cannabinoids are Δ(9)-tetrahydrocannabinol, which possesses psychoactive properties, and cannabidiol, which has no intrinsic psyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eb4344abd47449b904a37c310f557ad
https://pubmed.ncbi.nlm.nih.gov/25427150
https://pubmed.ncbi.nlm.nih.gov/25427150
Autor:
Todd J. Schwedt, Kavita Kalidas, David W. Dodick, Eric V. Hastriter, Alyssa Lettich, Eric P. Baron, Shira Y. Markowitz, Brigitte Lovell
Background It is generally felt that patient education and patient knowledge regarding triptan use for acute migraine management are important for successful and safe treatment. It is unclear how knowledgeable triptan users are regarding their tripta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b33f97b004df3990e439a6a2aacaae2
https://europepmc.org/articles/PMC4231778/
https://europepmc.org/articles/PMC4231778/
Autor:
Eric P. Baron, David W. Dodick, Rashmi B. Halker, Shira Y. Markowitz, Kavita Kalidas, Todd J. Schwedt, Rebecca Erwin Wells, Paul Mathew, Joseph G. Hentz
To identify factors associated with triptan discontinuation among migraine patients.It is unclear why many migraine patients who are prescribed triptans discontinue this treatment. This study investigated correlates of triptan discontinuation with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e397d48901d9845da0a21ace4f03c3
https://europepmc.org/articles/PMC3995344/
https://europepmc.org/articles/PMC3995344/
Autor:
Anna Baumgras, Maureen Beasley-Greenwood, Roy G. Beran, Mark Cooney, Adair Crosley, Mark S. Gold, Bruce A. Goldberger, Mark J. Greenwood, Richard A. Greer, Peter J. Hammer, Kavita Kalidas, Susan C. Kim, Janine Kremling, Woodburne O. Levy, Sana Loue, Michele L. Merves, Norman S. Miller, Roger H. Peters, John M. Ray, Joel M. Silberberg, Werner U. Spitz, Sara Spratt, Lesley Stone, Frank E. Vandervort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a45f4fb4c0cbf67f8742265c2cb181e1
https://doi.org/10.1016/b978-0-12-496736-6.00024-4
https://doi.org/10.1016/b978-0-12-496736-6.00024-4
Autor:
Woodburne O. Levy, Kavita Kalidas
Publisher Summary This chapter focuses on the historical perspective of drug use among athletes, elaborates on the reasons athletes use substances, and describes in detail both specific performance-enhancing and recreational drugs. Since the advent o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86d77c29d6d7785cdf3f6ebf8b5a8c4f
https://doi.org/10.1016/b978-0-12-496736-6.00018-9
https://doi.org/10.1016/b978-0-12-496736-6.00018-9